Scientist, In Vitro Assay Development & Drug Substance Delivery

Capricor Therapeutics(29 days ago)

San Diego, CAOnsiteFull TimeMedior$113,383 - $150,963 (estimated)Research and Development

About this role

The Scientist will lead the design, development, and validation of in vitro cellular assays to evaluate exosome- and nanoparticle-based delivery of diverse therapeutic payloads for rare diseases. This lab-based role focuses on mechanistic and functional characterization of drug delivery, therapeutic activity, and safety using advanced cell and molecular biology platforms. The position works closely with molecular biology, cell biology, bioanalytics, and translational research teams to support Capricor’s cell and exosome therapy pipeline. The role is based at Capricor’s San Diego research facilities in a fast-paced, highly collaborative environment.

View Original Listing

Required Skills

In Vitro Assays
Mechanism Of Action
PK/PD Assays
High Content Imaging
Flow Cytometry
qPCR
Western Blotting
ELISA
Exosome Delivery
Lipid Nanoparticles

+19 more

Qualifications

PhD in Cell Biology
PhD in Molecular Biology
PhD in Biochemistry
MS in Related Field

About Capricor Therapeutics

capricor.com

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.